Crossmark

Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies

Crossref DOI link: https://doi.org/10.1038/s41568-022-00490-1

Published Online: 2022-07-05

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Jixuan https://orcid.org/0000-0002-2209-3143
Pickett, Hilda A. https://orcid.org/0000-0002-9840-4841
License Information

Text and Data Mining valid from 2022-07-05

Version of Record valid from 2022-07-05
More Information

Article History

Accepted: 25 May 2022

First Online: 5 July 2022

Competing interests

: H.A.P. is a co-founder and shareholder of Tessellate Bio. J.G. declares no competing interests.